- Home
- MTZ vs PCVX Comparison
MTZ vs PCVX Comparison
Compare MTZ & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTZ
- PCVX
- Stock Information
- Founded
- MTZ 1929
- PCVX 2013
- Country
- MTZ United States
- PCVX United States
- Employees
- MTZ N/A
- PCVX N/A
- Industry
- MTZ Water Sewer Pipeline Comm & Power Line Construction
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- MTZ Industrials
- PCVX Health Care
- Exchange
- MTZ Nasdaq
- PCVX Nasdaq
- Market Cap
- MTZ 8.8B
- PCVX 4.3B
- IPO Year
- MTZ N/A
- PCVX 2020
- Fundamental
- Price
- MTZ $147.69
- PCVX $31.45
- Analyst Decision
- MTZ Strong Buy
- PCVX Strong Buy
- Analyst Count
- MTZ 17
- PCVX 10
- Target Price
- MTZ $157.81
- PCVX $136.50
- AVG Volume (30 Days)
- MTZ 909.0K
- PCVX 2.3M
- Earning Date
- MTZ 05-01-2025
- PCVX 05-07-2025
- Dividend Yield
- MTZ N/A
- PCVX N/A
- EPS Growth
- MTZ N/A
- PCVX N/A
- EPS
- MTZ 2.70
- PCVX N/A
- Revenue
- MTZ $12,464,333,000.00
- PCVX N/A
- Revenue This Year
- MTZ $10.26
- PCVX N/A
- Revenue Next Year
- MTZ $8.41
- PCVX N/A
- P/E Ratio
- MTZ $54.61
- PCVX N/A
- Revenue Growth
- MTZ 3.03
- PCVX N/A
- 52 Week Low
- MTZ $89.96
- PCVX $27.66
- 52 Week High
- MTZ $166.95
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- MTZ 73.40
- PCVX 37.17
- Support Level
- MTZ $121.82
- PCVX $28.09
- Resistance Level
- MTZ $128.24
- PCVX $36.71
- Average True Range (ATR)
- MTZ 5.18
- PCVX 2.47
- MACD
- MTZ 3.05
- PCVX 1.18
- Stochastic Oscillator
- MTZ 92.59
- PCVX 38.98
About MTZ MasTec Inc.
MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. The company's primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.